Insider Trading: Transition Therapeutics Inc (TTH.TO)
TTH.TO on Toronto Stock Exchange
3.14CAD
24 May 2013
3.14CAD
24 May 2013
Price Change (% chg)
$0.04 (+1.29%)
$0.04 (+1.29%)
Prev Close
$3.10
$3.10
Open
$3.10
$3.10
Day's High
$3.19
$3.19
Day's Low
$3.05
$3.05
Volume
12,499
12,499
Avg. Vol
4,476
4,476
52-wk High
$3.72
$3.72
52-wk Low
$1.74
$1.74
| SCHULER JACK W | Options Exercised: 0 | ||
| Trade Date: | Monday, 21 Nov 2011 | Price: | 1.35 |
| Title: | Beneficial Owner of More than 10% Class | Shares Held: | 2,823,010 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 1,925,926 |
Institutional Holders
| % Shares Owned: | 27.91% |
| # of Holders: | 21 |
| Total Shares Held: | 7,514,643 |
| 3 Mo. Net Change: | -435,722 |
| # New Positions: | 2 |
| # Closed Positions: | 1 |
| # Increased Positions: | 5 |
| # Reduced Positions: | 10 |
| # Net Buyers: | -5 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Tony Cruz |
59 | 1999 | Chairman of the Board, Chief Executive Officer |
Nicole Rusaw-George |
39 | 2012 | Chief Financial Officer |
Bruce Connop |
43 | 2012 | Vice President - Non-Clinical & Pharmaceutical Development |
Aleksandra Pastrak |
46 | 2011 | Vice President - Clinical Development and Medical Officer |
Carl Damiani |
39 | 2007 | Vice President - Business Development |
Louis Alexopoulos |
1998 | Secretary | |
Michael Ashton |
66 | 2012 | Lead Independent Director |
Paul Baehr |
69 | 2002 | Independent Director |
Christopher Henley |
52 | 2000 | Independent Director |
Gary Pace |
2012 | Independent Director |

